PHG News & Events

Philips and WellSpan Health announced a seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The collaboration includes a research agreement and joint innovation strategy, the first of its kind between Philips and a U.S. community health system, which will focus on validating the performance of new tools and technology. In addition, the innovation component of this relationship will allow WellSpan, together with Philips Research, to co-develop net-new products and features that advance care delivery. A long-term commercial agreement establishes Philips as WellSpan's preferred vendor across all applicable imaging modalities. The agreement covers all 12 WellSpan hospitals, as well as its diagnostic imaging centers and ambulatory surgery centers. A defining feature of the commercial agreement is its structured approach to technology lifecycle management: WellSpan and Philips will align equipment, service, training and upgrade planning under a single coordinated framework.

Philips announced regulatory clearance in the USA of Elevate Plus, bringing advanced imaging and a suite of AI and automation capabilities to Philips EPIQ Elite and Affiniti, its flagship ultrasound systems. With CE Mark and 510 clearance, Elevate Plus helps standardize routine exams and reduce the need for repeat scanning, delivering more consistent and high-quality ultrasound images faster across users.

Philips (PHG) and Disney (DIS) announced that Disney animated characters and stories are being incorporated directly into Philips Ambient Experience for MRI at medical facilities in 87 countries worldwide to support children undergoing imaging procedures.

LivaNova (LIVN) announced that Stefano Folli will join the Company as incoming President, Cardiopulmonary effective June 1, succeeding Franco Poletti, who will retire on July 31. Folli will partner closely with Poletti over the coming months to ensure a seamless leadership transition before assuming full responsibility for the business on August 1. Folli will join the LivaNova Executive Leadership Team and report to CEO Vladimir Makatsaria. In this role, Folli will oversee the strategic growth of the nearly $800-million business, which includes a complete range of Cardiopulmonary disposables and equipment, including the Essenz Perfusion System. Most recently, Folli served as Executive Vice President, Global President Ambulatory Monitoring & Diagnostics at Philips (PHG).